Skip to content
Low DoseGLP-1Providers

Provider review

Wisp review

Semaglutide as drops under the tongue rather than an injection, and a candid sourcing note.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated August 2026

We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.

$225/mo sublingual semaglutide drops, after a $99 consult

Visit Wisp

The bottle is sold by volume with no concentration, so the one calculation the format makes easy is the one you cannot do.

Price as published

Wisp

$225/mo sublingual semaglutide drops, after a $99 consult

Vs median
$50/mo above the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

In one paragraph

The verdict

The interesting thing here is the route. Almost everything on this page is a weekly subcutaneous injection, and for a reader deliberately holding a small dose that vehicle is the awkward part — a quarter dose means drawing a partial unit and trusting the markings on a syringe. Drops under the tongue sidestep that entirely, and Wisp is one of a handful of sellers offering them as a stocked product with a published price rather than something quoted on request. Two caveats travel with it, and Wisp states both itself rather than leaving them to be found. The first is that the product is described by volume and not by concentration, so there is no milligram anywhere: you cannot work out what a dose costs, how many doses a bottle holds, or whether taking less makes the bottle last longer, which is precisely the calculation the format would otherwise make easy. The second is in the footer, where the company discloses that the medications it offers are globally sourced and not FDA-approved and that the purchaser assumes that risk. That is a more candid disclosure than most of this category offers and it is also a material fact about provenance. The branded injectables are a different product entirely — prescriptions routed to a local pharmacy, with the pharmacy setting the price.

Visit Wisp

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

  • You want a needle-free route as a stocked product with a price, not quoted on request
  • You would rather a seller state its sourcing plainly than leave you to work it out
  • You have coverage and want branded prescriptions routed to your own pharmacy

Look elsewhere if

  • You want to cost a specific dose. The bottle is sold by volume with no concentration
  • You want one charge. A consult is billed before the medication figure applies
  • You want a product tested in people rather than on tissue. The company says which this is

What it actually costs

Price as published

$225/mo sublingual semaglutide drops, after a $99 consult

Vs median
$50/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
Market
$59–$1,300/mo is the full published spread on this site
Structure
Standard plan, self-directed low dose

No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.

235 of the 548 programs here price a small dose this way. A stocked sublingual product with a published price rather than injections only, which matters for a small dose because a drop count is easier to control than a partial unit in a syringe. The bottle is sold by volume with no concentration published, so you cannot work out what a dose costs or whether taking less makes the bottle last longer, the one calculation the format would otherwise make easy. A consult is charged separately before the medication price applies. The site's own footer says its medications are globally sourced and not FDA-approved. The branded injectables are sent to a local pharmacy and priced there, not here.

See Wisp's current price

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult
Confirm any separate fee
Dietitian
Not confirmed
Labs
Not required
Pricing
Check plan terms

What it does well

  • A stocked sublingual product with a published price, rather than injections only.
  • Discloses the sourcing and the regulatory status of its medications in its own footer.
  • Branded prescriptions can be routed to a local pharmacy for anyone with coverage.

Pharmacy, labs and oversight

Wisp does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. Confirm whether clinician visits cost extra.

Transparency check

2 of 4 published openly

What Wisp publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
Not published
A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
Published
What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
Not published
No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
None on file

How the program works

The interesting thing here is the route. Almost every seller here sells a weekly subcutaneous injection, and for a reader deliberately holding a small dose that vehicle is the awkward part — a quarter dose means drawing a partial unit and trusting the markings on a syringe. Drops under the tongue sidestep that entirely, and Wisp is one of a handful of sellers offering them as a stocked product with a published price rather than something quoted on request. Two caveats travel with it, and Wisp states both itself rather than leaving them to be found. The first is that the product is described by volume and not by concentration, so there is no milligram anywhere: a reader cannot work out what a dose costs, how many doses a bottle holds, or whether taking less makes the bottle last longer, which is precisely the calculation the format would otherwise make easy. The second is in the footer, where the company discloses that the medications it offers are globally sourced and not FDA-approved and that the purchaser is assuming that risk. That is a more candid disclosure than most of this category offers and it is also a material fact about provenance. The branded injectables are a different product entirely — prescriptions routed to a local pharmacy, with the pharmacy setting the price.

The honest cons

The bottle is sold by volume with no concentration, so no dose can be costed.
  • A consult is charged separately before the medication figure applies.
  • The company states the sublingual base was tested on tissue rather than in people.
Visit Wisp

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

Wisp is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Also consider

Two more programs that price a small dose the way Wisp does. Both are partners: we may earn a commission if you start care through these links.

Partner

RxSpan MD

$249/mo month to month ($199 on 6-mo)

Standard plan, self-directed low dose

Partner

HealthRX

$190/mo sema · $239/mo tirz (monthly plan)

Standard plan, self-directed low dose

Where this sits

#238 of 548

Ordered with the companies that pay us first, and Wisp is not one of them. A disclosed partition, not a score.

Compare all 548 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Start with Wisp

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

Willow

From $299/mo covering all four formats, none priced separately

Vs median
$124/mo above the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the Willow review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.